Fibroblast growth factor 2 level and its relation to severity of illness in patients with schizophrenia: cross-sectional case–control study

• Published in: Middle East Current Psychiatry Vol. 32; no. 1; pp. 43 - 10
• Main Authors: Shamseldin, Noha, Baz, Heba, Mostafa, Nehal, Shahin, Mostafa
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.12.2025; Springer; Springer Nature B.V; SpringerOpen
• Subjects: Brain research; Comorbidity; Dopamine; Drug use; Ethylenediaminetetraacetic acid; Factor; Fibroblast; Fibroblast growth factors; Fibroblasts; Growth; Growth factors; Intelligence; Interviews; Medical research; Medicine; Medicine & Public Health; Medicine, Experimental; Mental disorders; Nervous system; Neurogenesis; Pathophysiology; Psychiatry; Psychopathology; Schizophrenia; Severity; Social interaction; Sociodemographics; Stem cells; Substance use disorder; Egypt; Schizophrenia; Severity; Growth; Fibroblast; Factor

Background Schizophrenia (SCZ) is a severe and devastating psychiatric disorder with a lifetime prevalence of roughly 1%. Pathophysiology is intricate and little comprehended; nonetheless, genetics have a substantial role in the risk of this condition, with heritability exceeding 0.8. Fibroblast gro...